psoriasis Archives - Drugs in Context

Dermatology: how to manage psoriasis and recognize differences in pathophysiology and presentation in patients with skin of colour

Yuliya Lytvyn, Muskaan Sachdeva, Asfandyar Mufti, Jensen Yeung

Article Type

Review

Published

31 May 2022

the focus of this article is to review the current evidence on how epidemiology, clinical presentation and genetic differences in patients with skin of colour with psoriasis may impact treatment strategies.

Bimekizumab: the new drug in the biologics armamentarium for psoriasis

Egídio Freitas, Tiago Torres

Article Type

Editorial

Published

08 Jun 2021

Bimekizumab is mentioned in the recent report by Clarivate, Drugs to Watch in 2021, as one of the drugs to be observed in 2021. This article discusses the current status of bimekizumab.

Nail enthesis ultrasound and automated software-guided assessment of bilateral common carotid intima–media thickness in psoriasis and psoriatic arthritis: is there a correlation with clinical and laboratory findings?

José Alexandre Mendonça PhD, Lucas Nogueira Pansani MD, Mateus Basso Mimoto MD, Igor Tadeu Garcia Ferreira MD, Fernanda Bertucci Sanches MD, Thais de Campos Ferreira Pinto MD, Vania Aparecida Leandro-Merhi PhD, José Luis Braga de Aquino PhD

Article Type

Original Research

Published

03 Jun 2020

The objective of this study was to detect and correlate the changes that indicate the inflammatory and atherosclerotic process in psoriasis and psoriatic arthritis patients, using nail ultrasound and carotid artery intima–media thickness radiofrequency software.

Management of psoriasis in pregnancy – a review of the evidence to date

Clara Ferreira MD, Alexandra Azevedo MD, Miguel Nogueira MD, Tiago Torres MD, PhD

Article Type

Review

Published

09 Mar 2020

This article reviews the impact of psoriasis during pregnancy, how the disease can be managed pharmacologically during this period according to the available armamentarium, and the possible effects of the therapeutic options for the mother and the foetus.

Guselkumab for the treatment of psoriasis – evidence to date

Miguel Nogueira MD, Tiago Torres MD, PhD

Article Type

Review

Published

09 Jul 2019

This review highlights the evidence available to date for the use of guselkumab for the treatment of psoriasis. The results of the recent ECLIPSE trial are addressed.